E. Martínez

Randomized trial comparing pegylated interferon α‐2b versus pegylated interferon α‐2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients

C. Tural, J. Gatell, J. Mallolas, 2009, Hepatology.